Author: Katsanos, Aristeidis H.; Kyriakidi, Kalliroi; Karassa, Fotini B.; Politis, Dimitrios; Skamnelos, Alexandros; Christodoulou, Dimitrios K.; Katsanos, Konstantinos H.
Title: Biomarker Development in Chronic Inflammatory Diseases Cord-id: 87cccwap Document date: 2017_9_23
ID: 87cccwap
Snippet: Chronic inflammatory diseases, such as inflammatory bowel disease—namely, Crohn’s disease and ulcerative colitis—psoriasis, multiple sclerosis, rheumatoid arthritis, and many others affect millions of people worldwide, causing a high burden of disease, socioeconomic impact, and healthcare cost. These diseases have common features including autoimmune pathogenesis and frequent co morbidity. The treatment of these chronic inflammatory diseases usually requires long-term immunosuppressive the
Document: Chronic inflammatory diseases, such as inflammatory bowel disease—namely, Crohn’s disease and ulcerative colitis—psoriasis, multiple sclerosis, rheumatoid arthritis, and many others affect millions of people worldwide, causing a high burden of disease, socioeconomic impact, and healthcare cost. These diseases have common features including autoimmune pathogenesis and frequent co morbidity. The treatment of these chronic inflammatory diseases usually requires long-term immunosuppressive therapies with undesirable side effects. The future of chronic inflammatory disease prevention, detection, and treatment will be greatly influenced by the use of more effective biomarkers with enhanced performance. Given the practical issues of collecting tissue samples in inflammatory diseases, biomarkers derived from body fluids have great potential for optimized patient management through the circumvention of the abovementioned limitations. In this chapter, peripheral blood, urine, and cerebrospinal fluid biomarkers used in chronic inflammatory conditions are reviewed. In detail, this chapter reviews biomarkers to fore used or emerging to be used in patients with chronic inflammatory conditions. Those include inflammatory bowel diseases, chronic inflammatory conditions of the liver, biliary tract, pancreas, psoriasis, atopic disease, inflammatory skin diseases, rheumatic diseases, demyelination, and also the chronic inflammatory component of various other diseases in general medicine—including diabetes, cardiovascular disease, renal disease, and chronic obstructive pulmonary disease. Development of personalized medicine is closely linked to biomarkers, which may serve as the basis for diagnosis, drug discovery, and monitoring of diseases.
Search related documents:
Co phrase search for related documents- absence presence and active disease: 1, 2, 3
- absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and acute phase protein: 1
- absence presence and acute phase response: 1
- absence presence and adaptive immune response: 1, 2
- absence presence and adaptive immune response innate: 1
- absence presence and adipose tissue: 1, 2, 3, 4, 5
- absence presence and liver biopsy: 1
- absence presence and liver cirrhosis: 1, 2, 3, 4, 5
- absence presence and liver damage: 1, 2
- absence presence and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- absence presence and long period: 1, 2, 3, 4, 5
- absence presence and longitudinal design: 1, 2
- absence presence and longitudinal study: 1, 2, 3, 4, 5, 6
- absence presence and low extent: 1
- absence presence and low molecular: 1, 2, 3
- absence presence and low sensitivity: 1, 2, 3, 4, 5, 6, 7
- absence presence and lupus erythematosus: 1
- absence presence and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Co phrase search for related documents, hyperlinks ordered by date